Ventricular Assist Device Market : Key Trends and Forecast Research Report 2017 to 2023

1
Ventricular Assist Device Market Global Industry
Analysis, Trends, Market Size and Forecasts up
to 2023
2
A latest report has been added to the wide
database of Ventricular Assist Device Market by
Infinium Global Research. This report studies
the Ventricular Assist Device Market by type of
indication (left ventricular assist device,
right ventricular assist device, bi-ventricular
assist device), application (BTT, BTD,
destination, BTR therapy) market status and
outlook of global and major regions, from
manufacturers, and end industries. The objective
of the study is to identify market sizes of
different segments countries in recent years
and to forecast the values for the next six
years. Ventricular Assist Device Market provides
opportunities in micro markets for stakeholders
to invest along with the detailed analysis of
competitive landscape, latest trends, and
product offerings of the major companies in the
Ventricular Assist Device Market. According to
the report the Global Ventricular Assist Device
Market is projected to grow at a CAGR of 14.7 in
terms of value over the period of 2017-2023. A
VAD or Ventricular Assist Device is an
electromechanical pump that is implanted inside
a persons chest for assisting cardiac
circulation, which is used to either to partially
or to completely replace the function of a
weakened heart. A ventricular assist device is
dissimilar from an artificial cardiac pacemaker.
An artificial cardiac pacemaker replaces the
weak heart permanently, whereas a VAD works with
the heart to help it pump more blood with less
work. It does this by continuously taking blood
from the ventricle and moving it to the aorta,
which then delivers oxygen-rich blood throughout
the body. Some of the ventricular assist devices
are used for short term, typically for patients
recovering from myocardial infarction and for
patients recovering from heart surgery and some
are used for long-term, which includes for
patients suffering from advanced congestive
heart failure. Moreover, these ventricular assist
devices are designed to assist either right
ventricle or the left ventricle or to assist
both ventricles. Among these, LVAD implantations
are huge in number and accounted for highest
market share due to a high number of patients
suffering from left ventricular disease. Surgeons
implant this device as a treatment option for
severe heart conditions such as heart failures,
and chronic cardiac function disorders. The
ventricular assist devices mechanical pump has
both internal and external components. The
actual pump sits on or next to hearts ventricle
with a tube attached that routes the blood to
aorta. A cable called driveline extends from the
pump, out through the skin, and connects the pump
to a
3
controller and power sources worn outside the
body. Ventricular assist devices are used in
those patients who are suffering with class III
and class IV advanced heart diseases as per New
York Heart Association (NYHA) and patients who
are waiting for not suitable for heart
transplantation. Market Insights Some of the key
driving factors attributing to the growth of this
include increasing number of patients with
cardiovascular diseases such as hypertension,
heart failures and coronary artery diseases, and
shortage of number of heart donors. In addition,
changing lifestyle, alcohol consumption, growing
obesity and smoking further were propelling the
market growth, as these factors increase the bold
glucose and lipid levels, which results in
serious cardiovascular diseases. According to
American Heart Association publication, it has
been estimated that in the US alone
approximately 5.5 million people suffered from
heart failure in 2013 and 300,000 die each year
because of heart failure. However, there are
certain restraining factors which could hamper
the growth of the market, which includes, high
costs associated with the ventricular assist
device implantation compared to other therapies
available for CVD diseases and other serious
complications such as severe bleeding,
Immunosuppression, etc. Segment Covered The
report on global ventricular assist device market
covers segments such as, type of indication and
application. On the basis of type of indication
the global ventricular assist device market is
categorized into left ventricular assist device
(LVAD), right ventricular assist device (RVAD)
and bi-ventricular assist device (BI-VAD). On
the basis of application the global ventricular
assist device market is categorized into BTT
therapy BTD therapy, destination therapy and
BTR therapy.
4
Geographic Coverage The report provides regional
analysis covering geographies such as North
America, Europe, Asia-Pacific, and Rest of the
World. In this section the key trends and market
size for each geography is provided over the
period of 2015-2023. The countries covered in
the North America region include the U.S.,
Canada, and Mexico while Asia-Pacific includes
China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France,
Spain, and Rest of Europe are included in the
European region. The U.S. drives the growth in
the North America region as it is the largest
market in the region. The Asia-pacific region
offers a substantial potential for the market
growth owing to rapid growth in markets such as
India and China. The APAC region is projected to
experience a growth at a CAGR of x.x over the
period of 2017-2023. Companies Profiled The
report provides profiles of the companies in the
global ventricular assist device market such as,
Abiomed, Heart Ware International Inc., Thoratec
Corporation, Berlin Heart GmbH, Apaxis, Inc., Sun
Medical Technology Research, Terumo Corporation,
ReliantHeart, Jarvik Heart and Others. Click the
Below Full Report Link https//www.infiniumglobal
research.com/healthcare_medical_devices/ventricula
r_assist_device_vad_mar ket Report
Highlights The report provides deep insights on
demand forecasts, market trends and micro and
macro indicators. In addition, this report
provides insights on the factors that are driving
and restraining the global ventricular assist
device market. Moreover, IGR-Growth Matrix
analysis given in the report brings an insight on
the investment areas that existing or new market
players can consider. The report provides
insights into the
5
market using analytical tools such as Porter's
five forces analysis and DRO analysis of
ventricular assist device market. Moreover, the
study highlights current market trends and
provides forecast from 2017-2023. We also have
highlighted future trends in the ventricular
assist device market that will impact the demand
during the forecast period. Moreover, the
competitive analysis given in each regional
market brings an insight on the market share of
the leading players. This report will help
manufacturers, suppliers and distributors of the
ventricular assist device market to understand
the present and future trends in this market and
formulate their strategies accordingly. About
Us Infinium Global Research and Consulting
Solutions is started with a single motto of being
business partner of first choice. We at Infinium
work on the strengths of our clients to ensure we
help them consolidate their market position. We
firmly believe in the fact that if you are able
to develop newer opportunities then you find
there is no dearth of opportunities for you. With
our strategic research approaches and deep dive
in the market segments, we try to find out new
opportunities that our clients can encash with
their existing resources. Our experts with over
100 years of cumulative experience in research
offer the best in the industry services to our
clients to ensure that they achieve their
business goals. Browse Detailed TOC,
Description and Companies Mentioned in Report _at_
https//www.infiniumglobalresearch.com/healthcare_
medical_devices/ventricular_assist_device_vad_mar
ket